4° Horizons for Dravet syndrome
Internacionalni simpozij “Dravet syndrome and other sodium channel related encephalopathies” održan je 15.-17.03.2018. u Veroni u organizaciji Dravet Italia Onlus i Dravet Syndrome European Federation pod vodstvom najvećih svjetskih stručnjaka.
Oni su prezentirali najnovija saznanja iz područja molekularne genetike, životinjskih modela, primjene novih lijekova, povezanosti genetike i kognitivnih ishoda kod pacijenata, istraživanja smrtnosti i mogućih uzroka.
Sudjelovanje na konferenciji omogućila je hrvatskim stručnjacima dodatnu edukaciju o Dravet sindromu i drugim rezistentnim epileptičkim sindromima s krajnjim ciljem prilagođavanja tretmana pacijenta za bolji zdravstveni ishod.
Program simpozija:
Renzo Guerrini: From Dravet syndrome to sodium channel encephalopathies
Jeffrey Noebels: Sodium channel and human disease
Ingrid E. Scheffer: SCN1A related phenotypes
Rima Nabbout: Beyond the epilepsies in SCN1A diseases
Massimo Mantegazza: Mechanisms and models of SCN1A mutations
Vania Broccoli: SCN1A epigenome editing by the CRISPR/Cas9 system restores excitability and firing activity in Dravet inhibitory interneurons
Helen Cross: Cannabinoids in the treatment of Dravet syndrome
Renzo Guerrini: Stiripentol
Lieven Lagae: Fenfluramine in Dravet syndrome: Results of a phase 3 randomized, double-blind, placebo-controlled trial
Federico Vigevano: Management of prolonged seizure from prehospital treatment to intensive care unit
Francesca Darra: Long-term outcome of Dravet syndrome
Domenica Battaglia: Teenagers-Clinical cases
Francesca Ragona: Adults-Clinical cases
Pierre Genton: Long-term outcome of patients with Dravet syndrome: the Marseille experience
Bernardo Dalla Bernardina i Charlotte Dravet: a 40 year retrospective view of Dravet syndrome
Carla Marini: Dravet syndrome and its mimics
Markus Wolff: Phenotypic spectrum of SCN2A related disorders, treatment options and outcome
Andreas Brunklaus: The genetics of SCN2A
Holger Lerche: Mechanisms and models-SCN2A
Rikke Steensbjerre Moller: The genetics of SCN8A ena Gardella: Phenotypic spectrum of SCN8A-related disorders and treatment option outcome
Miriam H. Meisler: SCN8A mutations-mechanisms and models
Malo doživljaja sa simpozija možete pogledati ovdje:
Zahvaljujemo Zračnoj luci Split i Čistoći Split d.o.o. koji su nam potpomogli da ostvarimo svoj cilj.
